Search reports, ask a question, or jump to a page.
The problem
Intervention: Expansion of social security subsidization for diabetes treatment devices to enable near-universal access for children under 18 and young adults under 24 in higher education
Who it was tested with: Children with type 1 diabetes and young adults in higher education in Hungary; caregivers surveyed in 2018 (n=318) and 2025 (n=417).
Experience from people who deliver programmes: stories, case studies and lessons learned. Valuable for understanding how and why, and for spotting what to test next, but not a measure of effect.
"Repeated cross-sectional studies were conducted in 2018 (n = 318) and 2025 (n = 417) among caregivers of children with type 1 diabetes" with analysis of device use patterns before and after subsidization expansion. The comparison of two time-separated samples allows assessment of whether the policy change influenced technology adoption rates, though individual-level changes cannot be tracked.
The study design compares two separate cross-sectional samples rather than following the same individuals over time, so causality cannot be definitively established. The study does not measure clinical health outcomes or compare effectiveness between technology users and non-users.
Across countries and designs
1 study · 1 country
